These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 24725693

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
    Kirchheiner K, Nout RA, Lindegaard JC, Haie-Meder C, Mahantshetty U, Segedin B, Jürgenliemk-Schulz IM, Hoskin PJ, Rai B, Dörr W, Kirisits C, Bentzen SM, Pötter R, Tanderup K, EMBRACE Collaborative Group.
    Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Health related quality of life and patient reported symptoms before and during definitive radio(chemo)therapy using image-guided adaptive brachytherapy for locally advanced cervical cancer and early recovery - a mono-institutional prospective study.
    Kirchheiner K, Nout RA, Czajka-Pepl A, Ponocny-Seliger E, Sturdza AE, Dimopoulos JC, Dörr W, Pötter R.
    Gynecol Oncol; 2015 Mar; 136(3):415-23. PubMed ID: 25462202
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F, de Cuypere M, Viet Nguyen P, Jansen N, Warlimont B, Gulyban A, Gennigens C, Seidel L, Delbecque K, Coucke P, Hermesse J, Kridelka F.
    Acta Oncol; 2015 Mar; 54(9):1558-66. PubMed ID: 26406152
    [Abstract] [Full Text] [Related]

  • 10. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V, Choo BA, Lee KM, Tan TH, Low JH, Ng SY, Ilancheran A, Shen L, Tang J.
    Brachytherapy; 2017 Mar; 16(1):126-132. PubMed ID: 27816539
    [Abstract] [Full Text] [Related]

  • 11. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
    Dimopoulos JC, Schmid MP, Fidarova E, Berger D, Kirisits C, Pötter R.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1880-8. PubMed ID: 21868174
    [Abstract] [Full Text] [Related]

  • 12. Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study.
    Jensen NBK, Pötter R, Kirchheiner K, Fokdal L, Lindegaard JC, Kirisits C, Mazeron R, Mahantshetty U, Jürgenliemk-Schulz IM, Segedin B, Hoskin P, Tanderup K, EMBRACE Collaborative Group.
    Radiother Oncol; 2018 Jun 01; 127(3):431-439. PubMed ID: 29880222
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
    Kirchheiner K, Pötter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petrič P, Mahantshetty U, Jürgenliemk-Schulz IM, Rai B, Cooper R, Dörr W, Nout RA, EMBRACE Collaborative Group.
    Int J Radiat Oncol Biol Phys; 2016 Apr 01; 94(5):1088-98. PubMed ID: 26876955
    [Abstract] [Full Text] [Related]

  • 16. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
    Mohamed S, Lindegaard JC, de Leeuw AA, Jürgenliemk-Schulz I, Kirchheiner K, Kirisits C, Pötter R, Tanderup K.
    Radiother Oncol; 2016 Sep 01; 120(3):480-485. PubMed ID: 27267048
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
    Lee LJ, Viswanathan AN.
    Int J Radiat Oncol Biol Phys; 2012 Dec 01; 84(5):1192-7. PubMed ID: 22592049
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
    Mazeron R, Fokdal LU, Kirchheiner K, Georg P, Jastaniyah N, Šegedin B, Mahantshetty U, Hoskin P, Jürgenliemk-Schulz I, Kirisits C, Lindegaard JC, Dörr W, Haie-Meder C, Tanderup K, Pötter R, EMBRACE collaborative group.
    Radiother Oncol; 2016 Sep 01; 120(3):412-419. PubMed ID: 27396811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.